human embryonic-like extracellular matrix (Histogen/Histogen Oncology)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namehuman embryonic-like extracellular matrix (Histogen/Histogen Oncology)
Drug Alias Namehuman embryonic-like extracellular matrix (Histogen)human embryonic-like extracellular matrix (Histogen/Adaptive Biologix)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Embryonic stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHistogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdaptive Biologix LLCHistogen Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A